As part of a broader reorganization, General Electric plans to spin off its healthcare division in 2023.
GE Healthcare, which includes medical equipment, software and diagnostics, will become an independent publicly traded entity. General Electric will hold a 20% stake in the company.
In the press release After announcing the spin-off, General Electric stated that it would become “a pure company centered on precision health.”
By splitting its two divisions into new companies, the group hopes that its efforts will be more concentrated and the new entity will have greater flexibility to seek growth opportunities. GE Healthcare will be led by Peter Arduini, who will serve as the chief executive officer of the division from January next year.
GE CEO and Chairman Larry Culp stated in a press release that these changes will enable GE to “fully realize the potential of each of our businesses.”
Last year, General Electric’s health care department brought in 18 billion U.S. dollars in revenue. It develops MRI, CT scan, X-ray machine and other diagnostic equipment. It also sells software for clinical monitoring, ICU management, and anesthesia delivery.
Like other medical device companies, the pandemic has had an impact on GE’s business. It sees an increase in demand for ventilators, X-ray machines, surveillance solutions and other products related to the pandemic. At the same time, it saw a decrease in demand for other products, such as MRI machines and contrast agents.
In September, the The company acquired BK Medical, Expanding its ultrasound business to the operating room.
Derivatives are Part of a broader reorganization General Electric hopes to reverse its business and reduce debt. 2019 General Electric Sold its pharmaceutical business for US$21.4 billion To Danaher. The company also plans to divest its energy business in 2024, allowing GE’s core business to focus on aviation.
Image Credit: Scott Olson/Getty Images
